FTC Finalizes Consent Order in Amgen’s Acquisition of Horizon Therapeutics, Ensuring Continued Pharmaceutical Competition
The Federal Trade Commission (FTC) has recently finalized a consent order that resolves potential competition issues arising from Amgen Inc.’s acquisition of Horizon Therapeutics plc. This follows the dismissal of …
FTC Finalizes Consent Order in Amgen’s Acquisition of Horizon Therapeutics, Ensuring Continued Pharmaceutical Competition Read More